Further experiments showed that hypomethylation of the promoter regions of CAMK1D and CREB5 was associated with their upregulated expression, suggesting that these two genes may play an important role in the pathogenesis of MG through DNA methylation abnormalities (28). The gene discussed is CREB5; the disease is myasthenia gravis.